Cancer Therapy
Reports summarize cancer therapy research from National Institutes of Health
Published in Biotech Business Week, January 5th, 2009
New research, 'Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions,' is the subject of a report. According to recent research from the United States, "The activation of Akt/mammalian target of rapamycin (mTOR) pathway represents a frequent event in squamous cell carcinoma (SCC) progression, thus raising the possibility of using specific mTOR inhibitors for the treatment of SCC patients. In this regard, blockade of mTOR with rapamycin prevents the growth of human head and neck SCC cells when xenotransplanted into immunodeficient mice."
"However, therapeutic responses in xenograft tumors are not always...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Instituto Gulbenkian de Ciencia
First experimental evidence for speedy adaptation to pesticides by worm species - JAMA and Archives Journals
Among older adults, prescription and over-the-counter medications are commonly used together - MedInsight Research Institute
New study shows that a cough medicine ingredient could effectively treat prostate cancer - NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Hepatitis C treatment reduces the virus but liver damage continues - Research
Blind man walking: With no visual awareness, man navigates obstacle course flawlessly - Saint Louis University
Using math to understand hep. C: Patterns paint picture of who will respond to treatment - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
